Literature DB >> 25931169

Topiramate maculopathy secondary to dose titration: first reported case.

P S Severn1, R Symes1, R Rajendram1, B Pal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25931169      PMCID： PMC4506333          DOI： 10.1038/eye.2015.45

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Presumed topiramate-induced maculopathy.

Authors:  Stefan Beyenburg; Christophe Weyland; Markus Reuber
Journal:  Epilepsy Behav       Date:  2009-01-14       Impact factor: 2.937

Review 2.  Topiramate in migraine prophylaxis.

Authors:  D D'Amico; L Grazzi; S Usai; F Moschiano; G Bussone
Journal:  Neurol Sci       Date:  2005-05       Impact factor: 3.307

3.  Topiramate maculopathy.

Authors:  William Gualtieri; Jan Janula
Journal:  Int Ophthalmol       Date:  2012-09-28       Impact factor: 2.031

4.  Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.

Authors:  M D Privitera; M J Brodie; R H Mattson; D W Chadwick; W Neto; S Wang
Journal:  Acta Neurol Scand       Date:  2003-03       Impact factor: 3.209
  4 in total
  3 in total

1.  Comment on 'Topiramate maculopathy secondary to dose titration: first reported case'.

Authors:  P Kozner; S K Wagner; B Brozek; S Althauser
Journal:  Eye (Lond)       Date:  2015-10-16       Impact factor: 3.775

2.  Response to 'Comment on Topiramate maculopathy secondary to dose titration: first reported case'.

Authors:  R J Symes; P S Severn; R Rajendram; B Pal
Journal:  Eye (Lond)       Date:  2015-10-16       Impact factor: 3.775

3.  Topiramate-induced maculopathy in IgG4-related disease.

Authors:  Joanna DaCosta; Saad Younis
Journal:  Drug Healthc Patient Saf       Date:  2016-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.